NCT06076759View on ClinicalTrials.gov

Intrathecal Dexmedetomidine Versus Intrathecal Morphine Inpatients Undergoing Cardiac Valve Replacement Surgeries

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 1, 2024

Study Completion Date

November 30, 2024

Conditions
Cardiac Valve Disease
Interventions
DRUG

Intrathecal morphine or dexmedetomidine

Intrathecal injection

All Listed Sponsors
lead

Assiut University

OTHER

NCT06076759 - Intrathecal Dexmedetomidine Versus Intrathecal Morphine Inpatients Undergoing Cardiac Valve Replacement Surgeries | Biotech Hunter | Biotech Hunter